Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

Halozyme Therapeutics, Inc. ("Halozyme") today announced it will release its fourth quarter and full year 2024 financial and operating results on Tuesday, February 18, 2025, following the close of ...

Upgraded Points' latest study highlights which U.S. cities lead the charge in adopting digital payment methods for a wide ...